Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1998049306) HUMAN C-TYPE LECTIN
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/049306 International Application No.: PCT/US1998/008791
Publication Date: 05.11.1998 International Filing Date: 29.04.1998
IPC:
A61K 38/00 (2006.01) ,C07K 14/705 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
705
Receptors; Cell surface antigens; Cell surface determinants
Applicants:
INCYTE PHARMACEUTICALS, INC. [US/US]; 3174 Porter Drive Palo Alto, CA 94304, US (AM, AT, AU, AZ, BE, BF, BJ, BR, BY, CA, CF, CG, CH, CI, CM, CN, CY, DE, DK, ES, FI, FR, GA, GB, GH, GM, GN, GR, IE, IL, IT, JP, KE, KG, KR, KZ, LS, LU, MC, MD, ML, MR, MW, MX, NE, NL, NO, NZ, PT, RU, SD, SE, SG, SN, SZ, TD, TG, TJ, TM, UG, ZW)
BANDMAN, Olga [US/US]; US (UsOnly)
SHAH, Purvi [IN/US]; US (UsOnly)
Inventors:
BANDMAN, Olga; US
SHAH, Purvi; US
Agent:
BILLINGS, Lucy, J.; Incyte Pharmaceuticals, Inc. 3174 Porter Drive Palo Alto, CA 94304, US
Priority Data:
08/846,52329.04.1997US
Title (EN) HUMAN C-TYPE LECTIN
(FR) LECTINE HUMAINE DE TYPE C
Abstract:
(EN) The present invention provides a human C-type lectin (CTL-1) and polynucleotides which encode CTL-1. The invention also provides expression vectors, host cells, agonists, antisense molecules, antibodies or antagonists. The invention also provides methods for treating disorders associated with expression of CTL-1.
(FR) Nouvelle lectine humaine de type C (CTL-1) et polynucléotides qui codent ladite CTL-1. La présente invention concerne également des vecteurs d'expression, des cellules hôtes, des agonistes, des molécules antisens, des anticorps ou des antagonistes, ainsi que des méthodes de traitement de pathologies associées à l'expression de CTL-1.
Designated States: AT, AU, BR, CA, CH, CN, DE, DK, ES, FI, GB, IL, JP, KR, MX, NO, NZ, RU, SE, SG, US
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
AU1998071721